AURKA and ovarian carcinoma: In earlier work, it has been observed that the amplification of AURKA was associated with sensitivity to PARP inhibitors in 39 ovarian cancer cell lines (Ihnen et al, 2013), indicating an underlying mechanistic link between the AURK and PARP pathways.